Hologic Inc (HOLX)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
$75.57
Buy
$75.99
$0.02 (+0.03%)
Prices updated at 02 Apr 2026, 21:08 EDT
| Prices minimum 15 mins delay
Prices in USD
Hologic Inc develops, manufactures and supplies diagnostics products, medical imaging systems and surgical products for women's health. Its products are used in diagnosis of human diseases and screen donated human blood and plasma.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. Stephen P. Macmillan
CEO
Mr. Stephen P. Macmillan
Most recent earnings
30 Sep 2025
Fiscal year end
30 Sep 2025
Employees
7,070
Head office
250 Campus Drive
Marlborough
United States
01752
Key personnel
Owner name | Salary |
|---|---|
Mr. Charles J. Dockendorff Independent Director | 0.12m |
Mr. Stephen P. Macmillan Chairman of the Board, Chief Executive Officer and President | 1.21m |
Dr. Martin D. Madaus,PhD Director | - |
Ms. Amy A. Wendell Lead Independent Director | 0.12m |
Ms. Karleen M. Oberton Chief Financial Officer | 0.69m |
Ms. Stacey D. Stewart Independent Director | 0.09m |
Dr. Ludwig N. Hantson, PhD Independent Director | 0.09m |
Ms. Christiana Stamoulis, M.B.A. Independent Director | 0.09m |
Mr. Benjamin J. Cohn Vice President, Corporate Controller and Principal Accounting Officer | - |
Mr. Wayde D. McMillan Director | - |
Ms. Nanaz Mohtashami Independent Director | 0.09m |
Ms. Diana De Walt Senior Vice President, Human Resources | - |
Mr. Essex D. Mitchell Chief Operating Officer | 0.59m |
Mr. Jan Verstreken Group President, International | 0.69m |
Ms. Jennifer Schneiders President, Diagnostics Solutions | - |
Mr. Brandon Schnittker Division President, GYN Surgical Solutions | - |
Mr. Mark Horvath Division President, Breast and Skeletal Health Solutions | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard | 42,411,449 |
| Vanguard High Yield Corporate Fund | 31,270,000 |
| Vanguard Group Inc | 26,089,403 |
| BlackRock Inc | 19,413,701 |
| State Street Corp | 9,976,767 |
Director dealings
Date | Action |
|---|---|
| 12 Dec 2025 | - |
| 14 Nov 2025 | - |
| 14 Nov 2025 | - |
| 14 Nov 2025 | - |
| 14 Nov 2025 | - |
| 14 Nov 2025 | - |
| 14 Nov 2025 | - |
| 14 Nov 2025 | - |
| 14 Nov 2025 | - |
| 10 Nov 2025 | - |
| 11 Nov 2025 | - |
| 10 Nov 2025 | - |
| 07 Nov 2025 | - |
| 10 Nov 2025 | - |
| 07 Nov 2025 | - |
| 11 Nov 2025 | - |
| 11 Nov 2025 | - |
| 10 Nov 2025 | - |
| 07 Nov 2025 | - |
| 10 Nov 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
